Ionis Pharmaceuticals Inc (IONS) — Financial Flexibility Index
Ionis Pharmaceuticals Inc (IONS) has a Financial Flexibility Index of 0.23x as of June 2026. Free cash flow of $581.61 Million (operating CF $565.53 Million minus capex $16.08 Million) represents 0% of total liabilities ($2.56 Billion). Check Ionis Pharmaceuticals Inc cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Ionis Pharmaceuticals Inc Financial Flexibility Index (1991–2025)
Historical Financial Flexibility Index trend for Ionis Pharmaceuticals Inc across 35 annual periods. For the full cash flow conversion analysis, see Ionis Pharmaceuticals Inc (IONS) cash conversion ratio.
Annual Financial Flexibility Index for Ionis Pharmaceuticals Inc (1991–2025)
Year-by-year free cash flow to debt coverage for Ionis Pharmaceuticals Inc. Explore IONS cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.07x | $-217.14 Million | $-268.58 Million | $3.03 Billion | ▲ +62.1% |
| 2024 | -0.19x | $-455.67 Million | $-500.95 Million | $2.42 Billion | ▼ -75.7% |
| 2023 | -0.11x | $-279.50 Million | $-307.51 Million | $2.60 Billion | ▲ +17.2% |
| 2022 | -0.13x | $-254.27 Million | $-274.37 Million | $1.96 Billion | ▼ -589.9% |
| 2021 | 0.03x | $48.70 Million | $30.80 Million | $1.84 Billion | ▼ -46.8% |
| 2020 | 0.05x | $76.94 Million | $35.89 Million | $1.55 Billion | ▼ -79.8% |
| 2019 | 0.25x | $382.00 Million | $345.72 Million | $1.55 Billion | ▼ -41.1% |
| 2018 | 0.42x | $620.54 Million | $602.89 Million | $1.48 Billion | ▲ +78.6% |
| 2017 | 0.23x | $212.01 Million | $174.15 Million | $903.30 Million | ▲ +289.7% |
| 2016 | -0.12x | $-100.58 Million | $-112.11 Million | $812.90 Million | ▼ -384.3% |
| 2015 | 0.04x | $32.87 Million | $21.12 Million | $755.32 Million | ▲ +74.7% |
| 2014 | 0.02x | $17.39 Million | $6.29 Million | $698.03 Million | ▼ -83.0% |
| 2013 | 0.15x | $68.86 Million | $63.49 Million | $468.77 Million | ▲ +656.6% |
| 2012 | 0.02x | $7.05 Million | $1.88 Million | $362.92 Million | ▲ +105.9% |
| 2011 | -0.33x | $-103.80 Million | $-114.80 Million | $313.46 Million | ▼ -120.1% |
| 2010 | -0.15x | $-46.04 Million | $-63.59 Million | $305.94 Million | ▲ +42.0% |
| 2009 | -0.26x | $-92.15 Million | $-108.44 Million | $355.12 Million | ▼ -153.2% |
| 2008 | 0.49x | $229.10 Million | $212.03 Million | $469.90 Million | ▲ +194.9% |
| 2007 | 0.17x | $41.10 Million | $36.09 Million | $248.62 Million | ▲ +151.6% |
| 2006 | -0.32x | $-50.67 Million | $-53.23 Million | $158.00 Million | ▲ +14.4% |
| 2005 | -0.37x | $-61.32 Million | $-61.74 Million | $163.71 Million | ▼ -7.0% |
| 2004 | -0.35x | $-98.22 Million | $-101.75 Million | $280.56 Million | ▼ -6.6% |
| 2003 | -0.33x | $-87.92 Million | $-95.47 Million | $267.76 Million | ▼ -61.6% |
| 2002 | -0.20x | $-57.55 Million | $-94.38 Million | $283.21 Million | ▼ -1359.6% |
| 2001 | 0.02x | $3.13 Million | $-6.16 Million | $193.96 Million | ▲ +108.8% |
| 2000 | -0.18x | $-21.54 Million | $-23.19 Million | $116.89 Million | ▲ +56.8% |
| 1999 | -0.43x | $-43.60 Million | $-48.40 Million | $102.31 Million | ▼ -41.1% |
| 1998 | -0.30x | $-30.30 Million | $-34.70 Million | $100.30 Million | ▼ -46.6% |
| 1997 | -0.21x | $-17.10 Million | $-20.60 Million | $83.00 Million | ▲ +56.5% |
| 1996 | -0.47x | $-20.30 Million | $-21.20 Million | $42.90 Million | ▲ +19.9% |
| 1995 | -0.59x | $-14.00 Million | $-15.10 Million | $23.70 Million | ▲ +14.9% |
| 1994 | -0.69x | $-14.30 Million | $-15.20 Million | $20.60 Million | ▼ -39.5% |
| 1993 | -0.50x | $-10.10 Million | $-15.30 Million | $20.30 Million | ▲ +54.8% |
| 1992 | -1.10x | $-17.30 Million | $-19.40 Million | $15.70 Million | ▼ -1241.3% |
| 1991 | 0.10x | $1.40 Million | $-1.50 Million | $14.50 Million | — |